Philippe Lienard obtained his PhD in organic chemistry at the CNRS, French National Research Center, in Pr Husson’s team, in 1991. After having performed a post-doc in the prestigious Pr Oppolzer’s laboratory in Switzerland, he joined SYNTHELABO in 1993 in chemical development. He occupied several positions including Head of Pilot Plant for 12 years. In 2003, He was expatriated in the USA for 3 years for SANOFI, as Chemical Development Director. Back to France in 2006, he has been working within early Pharmaceutical Sciences Department for 10 years and he’s currently Pre Development Science leader for several programs at the interface of Research and Development.
Helen Hao Hou
Senior Scientist Small Molecule Pharmaceutical Sciences
Dr. Helen Hou joined the Department of Small Molecule Pharmaceutical Sciences at Genentech (South San Francisco, California) in 2015. In her current role as a Senior Scientist, she is responsible for drug product development to allow fast-entry into human and the definition of market-image formulation/process. Prior to joining Genentech, Helen worked in several industrial positions at Allergan (2013 â€“2015), AbbVie (2008 â€“ 2013), and Amgen (2006 â€“ 2007), specialized in development of oral solid dosage forms and sterile product for ophthalmology. Helen received her Ph.D. in materials science and engineering from the University of Minnesota in 2006, where she did research in development of novel intranasal formulation for the treatment of epilepsy. Her primary research interests include understanding the effect of solubilizing additives on the manufacturability and release behavior of high-energy solids, and designing in vitro models for the prediction of in vivo performance of supersaturating solid dosage forms.
Senior Vice President CMC
Executive Director, Analytical Characterization, Formulation Development, and Biologics Manufacture
Senior Scientist- Formulation and Characterization
Smart Device Engineer
Jace Blackburn is a Smart Device Engineer at Genentech where he oversees development of Connected Device Platforms to improve the patient experience and enable new digital strategies for the business. He holds multiple certifications in Product Management and brings expertise on the development of software as a medical devices, connected devices, and digital combination products. He holds a degree in Chemical and Biological Engineering from the University of Colorado Boulder and is currently pursuing a Masters in Bioinformatics from Johns Hopkins University.